KENILWORTH, N.J., Sept. 19 /PRNewswire/ -- Schering-Plough Corporation (NYSE: SGP - News) announced today that its Board of Directors has elected Thomas P. Koestler, Ph.D., as executive vice president and president of Schering-Plough Research Institute (SPRI), the company’s pharmaceutical research and development arm.
